These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22349341)

  • 1. Current applications of high-resolution mass spectrometry in drug metabolism studies.
    Meyer MR; Maurer HH
    Anal Bioanal Chem; 2012 May; 403(5):1221-31. PubMed ID: 22349341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
    Ojanperä I; Kolmonen M; Pelander A
    Anal Bioanal Chem; 2012 May; 403(5):1203-20. PubMed ID: 22302167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyphenated high-resolution mass spectrometry-the "all-in-one" device in analytical toxicology?
    Maurer HH
    Anal Bioanal Chem; 2021 Apr; 413(9):2303-2309. PubMed ID: 33247339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current position of high-resolution MS for drug quantification in clinical & forensic toxicology.
    Meyer MR; Helfer AG; Maurer HH
    Bioanalysis; 2014 Aug; 6(17):2275-84. PubMed ID: 25383737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug confirmation by mass spectrometry: Identification criteria and complicating factors.
    Yuan C; Chen D; Wang S
    Clin Chim Acta; 2015 Jan; 438():119-25. PubMed ID: 25182671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent instrumental progress in mass spectrometry: advancing resolution, accuracy, and speed of drug detection.
    Thevis M; Volmer DA
    Drug Test Anal; 2012; 4(3-4):242-5. PubMed ID: 22374710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution mass spectrometry in toxicology: current status and future perspectives.
    Maurer HH; Meyer MR
    Arch Toxicol; 2016 Sep; 90(9):2161-2172. PubMed ID: 27369376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry.
    Zhang H; Zhang D; Ray K; Zhu M
    J Mass Spectrom; 2009 Jul; 44(7):999-1016. PubMed ID: 19598168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of mass spectrometry in drug metabolism: 50 years of progress.
    Wen B; Zhu M
    Drug Metab Rev; 2015 Feb; 47(1):71-87. PubMed ID: 25639893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents.
    Meyer MR; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(1):195-208. PubMed ID: 21866399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays.
    Marquet P
    Methods Mol Biol; 2012; 902():15-27. PubMed ID: 22767104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a five-channel multiplexed electrospray quadrupole time-of-flight hybrid mass spectrometer for metabolite identification.
    Leclercq L; Delatour C; Hoes I; Brunelle F; Labrique X; Castro-Perez J
    Rapid Commun Mass Spectrom; 2005; 19(12):1611-8. PubMed ID: 15915450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?
    Maurer HH
    J Chromatogr A; 2013 May; 1292():19-24. PubMed ID: 22964051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification.
    Liang Y; Wang G; Xie L; Sheng L
    Curr Drug Metab; 2011 May; 12(4):329-44. PubMed ID: 21395529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of in vitro technologies coupled with high resolution accurate mass LC-MS for studying drug metabolism in equine drug surveillance.
    Scarth JP; Spencer HA; Timbers SE; Hudson SC; Hillyer LL
    Drug Test Anal; 2010 Jan; 2(1):1-10. PubMed ID: 20878880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.